These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38793544)

  • 1. Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.
    Ray P; Ledgerwood-Lee M; Brickner H; Clark AE; Garretson A; Graham R; Van Zant W; Carlin AF; Aronoff-Spencer ES
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An indirect ELISA for detecting anti-SARS-CoV-2 antibodies in human sera using a baculovirus-expressed recombinant nucleocapsid antigen.
    Fogaça MBT; Crispim GJB; Saavedra DP; Lopes-Luz L; da Silva LA; de Camargo BR; Guimarães RA; Nagata T; Ribeiro BM; Bührer-Sékula S
    Biologicals; 2024 May; 86():101769. PubMed ID: 38759304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips.
    Xie C; Ding H; Ding J; Xue Y; Lu S; Lv H
    J Med Virol; 2022 Apr; 94(4):1633-1640. PubMed ID: 34904253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development.
    Cerutti H; Ricci V; Tesi G; Soldatini C; Castria M; Vaccaro MN; Tornesi S; Toppi S; Verdiani S; Brogi A
    J Clin Lab Anal; 2021 Apr; 35(4):e23735. PubMed ID: 33608968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of antigens expressed in Nicotiana benthamiana plant and Escherichia coli for the SARS-CoV-2 IgG antibody detection by ELISA.
    Fogaça MBT; Lopes-Luz L; Saavedra DP; de Oliveira NKAB; Jesus Sousa MB; Perez JDP; de Andrade IA; Crispim GJB; Pinto LDS; Ferreira MRA; Ribeiro BM; Nagata T; Conceição FR; Stefani MMA; Bührer-Sékula S
    J Virol Methods; 2024 Sep; 329():114969. PubMed ID: 38834144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
    Djukic T; Mladenovic M; Stanic-Vucinic D; Radosavljevic J; Smiljanic K; Sabljic L; Devic M; Cujic D; Vasovic T; Simovic A; Radomirovic M; Cirkovic Velickovic T
    Virology; 2021 May; 557():15-22. PubMed ID: 33582454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
    Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
    mBio; 2021 May; 12(3):. PubMed ID: 34006662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
    Yue L; Cao H; Xie T; Long R; Li H; Yang T; Yan M; Xie Z
    J Med Virol; 2021 Mar; 93(3):1732-1738. PubMed ID: 32965677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A safe, cost-effective, and high-throughput SARS-CoV-2 antigen capture ELISA suitable for large-scale screening in low-resource settings.
    Singh A; Sahu U; Kulkarni PM; Yadav R; Bhatia S; Murugkar HV; Hosamani M; Basagoudanavar S; Sharma GK; Gupta PK; Kumar N; Sanyal A; Kumar N
    J Virol Methods; 2024 Sep; 329():114995. PubMed ID: 38972641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
    Fisher M; Levy H; Fatelevich E; Afrimov Y; Ben-Shmuel A; Rosenfeld R; Noy-Porat T; Glinert I; Sittner A; Biber A; Belkin A; Bar-David E; Puni R; Levy I; Mazor O; Weiss S; Mechaly A
    Microbiol Spectr; 2021 Oct; 9(2):e0087021. PubMed ID: 34612689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody.
    Tian X; Mo C; Zhou L; Yang Y; Zhou Z; You A; Fan Y; Liu W; Li X; Zhou R
    Virus Res; 2021 Jul; 300():198445. PubMed ID: 33961897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.
    Yamaoka Y; Miyakawa K; Jeremiah SS; Funabashi R; Okudela K; Kikuchi S; Katada J; Wada A; Takei T; Nishi M; Shimizu K; Ozawa H; Usuku S; Kawakami C; Tanaka N; Morita T; Hayashi H; Mitsui H; Suzuki K; Aizawa D; Yoshimura Y; Miyazaki T; Yamazaki E; Suzuki T; Kimura H; Shimizu H; Okabe N; Hasegawa H; Ryo A
    Cell Rep Med; 2021 Jun; 2(6):100311. PubMed ID: 34027498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.
    Dai Y; Chen H; Zhuang S; Feng X; Fang Y; Tang H; Dai R; Tang L; Liu J; Ma T; Zhong G
    Pathog Glob Health; 2020 Dec; 114(8):463-470. PubMed ID: 33198594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
    Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community.
    Guarino C; Larson E; Babasyan S; Rollins A; Joshi LR; Laverack M; Parrilla L; Plocharczyk E; Diel DG; Wagner B
    PLoS One; 2022; 17(1):e0262868. PubMed ID: 35061843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.
    Moerman A; Vernelen K; China B; Capron A; Bossche DVD; Mariën J; Ariën KK; Van Acker J; Delforge ML; Reynders M; Boel A; Depypere M; Van Gasse N; Vijgen S; Brauner J; Dujardin B; Padalko E
    Diagn Microbiol Infect Dis; 2022 Feb; 102(2):115561. PubMed ID: 34773801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paper-based microfluidic chip for rapid detection of SARS-CoV-2 N protein.
    Sun M; Han M; Xu S; Yan K; Nigal G; Zhang T; Song B
    Bioengineered; 2022 Jan; 13(1):876-883. PubMed ID: 34968171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Detection Antibody Targeting the Linear Epitope in SARS-CoV-2 Nucleocapsid Protein with Ultra-High Sensitivity.
    Wu F; Jiang Y; Yang H; Ma L
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.